Angiotensin-Converting Enzyme (ACE) inhibitors have also been used for the prevention of AP in patients with dysphagia by decreasing the degradation of bradykinin and tachykinins, including substance P (SP). This evidence concerns the gene ACE and alkaline phosphatase measurement.